Access cutting-edge wet macular degeneration treatment through this clinical trial at a research site in Campbell. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Campbell location
Access wet macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related wet macular degeneration treatment provided free
Check if you qualify for this wet macular degeneration clinical trial in Campbell, CA
No-Cost Study Care
Local to Campbell
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
RGX-314 is being developed as a potential novel one-time gene therapy treatment for the treatment of neovascular (wet) age related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-VEGF therapies have significantly changed the landscape for tre
Sponsor: AbbVie
Yes, this clinical trial (NCT04514653) has an active research site in Campbell, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for wet macular degeneration treatment options in Campbell, CA, this clinical trial (NCT04514653) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Campbell research site is actively enrolling participants for this clinical trial. You'll receive care from experienced wet macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all wet macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Campbell — not just this study.
Browse Essential Tremor Trials in Campbell →